Form 4: BeiGene CEO Sells Shares
Insider Transaction (Form 4)
John Oyler, Chief Executive Officer and a Director of BeiGene, Ltd., sold 109,713 shares of common stock on July 20, 2026.
Summary
- Open-market sale: disposed of 5,146 American Depositary Shares at $310.08 ($1,595,678) on July 20, 2026; holds 9,180 after (Direct).
- Open-market sale: disposed of 6,273 American Depositary Shares at $310.75 ($1,949,310) on July 20, 2026; holds 2,907 after (Direct).
- Open-market sale: disposed of 2,907 American Depositary Shares at $311.80 ($906,389) on July 20, 2026 (Direct).
- Option exercise/conversion: acquired 33,990 American Depositary Shares at $119.96 ($4,077,440) on July 20, 2026; holds 33,990 after (Direct).
- Open-market sale: disposed of 15,499 American Depositary Shares at $312.29 ($4,840,115) on July 20, 2026; holds 18,491 after (Direct).
- Open-market sale: disposed of 14,326 American Depositary Shares at $312.96 ($4,483,433) on July 20, 2026; holds 4,165 after (Direct).
- Open-market sale: disposed of 1,850 American Depositary Shares at $313.91 ($580,732) on July 20, 2026; holds 2,315 after (Direct).
- Open-market sale: disposed of 1,512 American Depositary Shares at $315.26 ($476,678) on July 20, 2026; holds 803 after (Direct).
- Open-market sale: disposed of 523 American Depositary Shares at $316.14 ($165,339) on July 20, 2026; holds 280 after (Direct).
- Open-market sale: disposed of 280 American Depositary Shares at $318.30 ($89,124) on July 20, 2026 (Direct).
- Open-market sale: disposed of 15,379 American Depositary Shares at $316.26 ($4,863,766) on July 21, 2026; holds 46,018 after (Direct).
- Open-market sale: disposed of 20,029 American Depositary Shares at $316.91 ($6,347,340) on July 21, 2026; holds 25,989 after (Direct).
- Open-market sale: disposed of 7,842 American Depositary Shares at $318.41 ($2,496,997) on July 21, 2026; holds 18,147 after (Direct).
- Open-market sale: disposed of 15,807 American Depositary Shares at $319.29 ($5,047,019) on July 21, 2026; holds 2,340 after (Direct).
- Open-market sale: disposed of 2,340 American Depositary Shares at $320.06 ($748,936) on July 21, 2026 (Direct).
- Option exercise/conversion: disposed of 441,870 Share Option (Right to Buy) on July 20, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $34,590,855 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
John Oyler — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-20 | Open-market sale | American Depositary Shares | 5,146 | $310 | $1.6M | 9,180 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 6,273 | $311 | $1.9M | 2,907 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 2,907 | $312 | $906.4K | 0 |
| 2026-07-20 | Option exercise/conversion | American Depositary Shares | 33,990 | $120 | $4.1M | 33,990 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 15,499 | $312 | $4.8M | 18,491 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 14,326 | $313 | $4.5M | 4,165 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 1,850 | $314 | $580.7K | 2,315 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 1,512 | $315 | $476.7K | 803 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 523 | $316 | $165.3K | 280 |
| 2026-07-20 | Open-market sale | American Depositary Shares | 280 | $318 | $89.1K | 0 |
| 2026-07-21 | Open-market sale | American Depositary Shares | 15,379 | $316 | $4.9M | 46,018 |
| 2026-07-21 | Open-market sale | American Depositary Shares | 20,029 | $317 | $6.3M | 25,989 |
| 2026-07-21 | Open-market sale | American Depositary Shares | 7,842 | $318 | $2.5M | 18,147 |
| 2026-07-21 | Open-market sale | American Depositary Shares | 15,807 | $319 | $5.0M | 2,340 |
| 2026-07-21 | Open-market sale | American Depositary Shares | 2,340 | $320 | $748.9K | 0 |
| 2026-07-20 | Option exercise/conversion | Share Option (Right to Buy) | 441,870 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-20 | Open-market sale (5,146 shares) |
| 2026-07-20 | Open-market sale (6,273 shares) |
| 2026-07-20 | Open-market sale (2,907 shares) |
| 2026-07-20 | Option exercise/conversion (33,990 shares) |
| 2026-07-20 | Open-market sale (15,499 shares) |
| 2026-07-20 | Open-market sale (14,326 shares) |
| 2026-07-20 | Open-market sale (1,850 shares) |
| 2026-07-20 | Open-market sale (1,512 shares) |
| 2026-07-20 | Open-market sale (523 shares) |
| 2026-07-20 | Open-market sale (280 shares) |
| 2026-07-21 | Open-market sale (15,379 shares) |
| 2026-07-21 | Open-market sale (20,029 shares) |
| 2026-07-21 | Open-market sale (7,842 shares) |
| 2026-07-21 | Open-market sale (15,807 shares) |
| 2026-07-21 | Open-market sale (2,340 shares) |
| 2026-07-20 | Option exercise/conversion (441,870 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, John Oyler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.